# Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease

> **NCT01001637** · NA · TERMINATED · sponsor: **Jaslok Hospital and Research Centre** · enrollment: 26 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Curcumin Formulation
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01001637
- **Lead sponsor:** Jaslok Hospital and Research Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-11
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** lack of support
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001637, "Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01001637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*